Table of Content
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in genitourinary dealmaking
2.1. Introduction
2.2. Genitourinary partnering over the years
2.3. Genitourinary partnering by deal type
2.4. Genitourinary partnering by industry sector
2.5. Genitourinary partnering by stage of development
2.6. Genitourinary partnering by technology type
2.7. Genitourinary partnering by therapeutic indication
Chapter 3 – Financial deal terms for genitourinary partnering
3.1. Introduction
3.2. Disclosed financials terms for genitourinary partnering
3.3. Genitourinary partnering headline values
3.4. Genitourinary deal upfront payments
3.5. Genitourinary deal milestone payments
3.6. Genitourinary royalty rates
Chapter 4 – Leading genitourinary deals and dealmakers
4.1. Introduction
4.2. Most active in genitourinary partnering
4.3. List of most active dealmakers in genitourinary
4.4. Top genitourinary deals by value
Chapter 5 – Genitourinary contract document directory
5.1. Introduction
5.2. Genitourinary partnering deals where contract document available
Chapter 6 – Genitourinary dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by genitourinary therapeutic target
Deal directory
Deal directory – Genitourinary deals by company A-Z 2016 to 2023
Deal directory – Genitourinary deals by technology type 2016 to 2023
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering
Table of figures
Figure 1: Genitourinary partnering since 2016
Figure 2: Genitourinary partnering by deal type since 2016
Figure 3: Genitourinary partnering by industry sector since 2016
Figure 4: Genitourinary partnering by stage of development since 2016
Figure 5: Genitourinary partnering by technology type since 2016
Figure 6: Genitourinary partnering by indication since 2016
Figure 7: Genitourinary deals with a headline value
Figure 8: Genitourinary deals with upfront payment values
Figure 9: Genitourinary deals with milestone payment
Figure 10: Genitourinary deals with royalty rates
Figure 11: Active genitourinary dealmaking activity since 2016
Figure 12: Top genitourinary deals by value since 2016